Current Treatment Options in Oncology

SCI期刊
Current Treatment Options in Oncology
中文名称:
目前肿瘤学的治疗方案
期刊缩写:
CURR TREAT OPTION ON
影响因子:
3.8
ISSN:
print: 1527-2729
on-line: 1534-6277
研究领域:
ONCOLOGY-
创刊年份:
2000年
h-index:
48
自引率:
0.00%
Gold OA文章占比:
20.75%
原创研究文献占比:
0.00%
SCI收录类型:
Science Citation Index Expanded (SCIE) || Scopus (CiteScore)
期刊介绍英文:
This journal aims to review the most important, recently published treatment option advances in the field of oncology. By providing clear, insightful, balanced contributions by international experts, the journal intends to facilitate worldwide approaches to cancer treatment. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as endocrine tumors, lymphomas, neuro-oncology, and cancers of the breast, head and neck, lung, skin, gastrointestinal tract, and genitourinary region. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. We also provide commentaries from well-known oncologists, and an international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
7.11.3261.258
学科
排名
百分位
大类:Medicine
小类:Pharmacology (medical)
53 / 272
80%
大类:Medicine
小类:Oncology
93 / 404
77%
发文信息
中科院SCI期刊分区
大类 小类 TOP期刊 综述期刊
2区 医学
3区 肿瘤学 ONCOLOGY
WOS期刊分区
学科分类
Q2ONCOLOGY
历年影响因子
2015年2.1270
2016年2.8200
2017年3.5620
2018年3.8510
2019年3.9000
2020年5.0360
2021年5.0800
2022年4.3000
2023年3.8000
历年发表
2012年44
2013年51
2014年48
2015年60
2016年63
2017年75
2018年81
2019年91
2020年107
2021年112
2022年113
投稿信息
出版周期:
Bimonthly
出版语言:
English
出版国家(地区):
US
初审时长:
62 days
审稿时长:
>12 weeks
出版商:
Springer US
编辑部地址:
SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Current Treatment Options in Oncology - 最新文献

Updates in Systemic Treatment of Hormone Receptor-Positive Early-Stage Breast Cancer.

Pub Date : 2024-10-03 DOI: 10.1007/s11864-024-01258-5 Emily Hsu, Sabrina M Arezo, Stephanie L Graff

The Role of SIRT1 in Leukemia.

Pub Date : 2024-10-02 DOI: 10.1007/s11864-024-01265-6 Zhongqi Wu, Tianxin Lyu, Leizhen Wu, Hui Yang, Wenqiang Li

Clinical Trial Data Review of the Combination FTD/TPI + Bevacizumab in the Treatment Landscape of Unresectable Metastatic Colorectal Cancer.

Pub Date : 2024-09-26 DOI: 10.1007/s11864-024-01261-w Thierry André, Eric Van Cutsem, Julien Taieb, Marwan Fakih, Gerald W Prager, Fortunato Ciardiello, Alfredo Falcone, Mark Saunders, Nadia Amellal, Lucas Roby, Josep Tabernero, Per Pfeiffer
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信